Dr. Corbett is the Chairman of the Board of INVIA. In that position he is responsible for the strategic direction of the Company, as well as directing clinical validation.
He has over 25 years of experience in nuclear cardiology, with specializations in Cardiovascular Disease and Nuclear Cardiology.
For 12 years he was with the University of Texas Health Science Center, where he moved up to the position of Director of Nuclear Cardiology. He has been at the University of Michigan Medical Center, Division of Nuclear Medicine, for 14 years, where his current appointment is as Professor of Internal Medicine, Professor of Radiology and the Director of Cardiovascular Nuclear Medicine.
Among his many accomplishments, he was one of the founding research investigators in gated perfusion tomography, being first to develop a commercially available computer application to generate quantitative 3 dimensional displays of measured heart blood-flow and function. Dr. Corbett has 75 peer-reviewed writings to his credit, which were published in various scientific journals. His numerous other writings include book chapters, non-peer reviewed publications and abstracts. These writings are predominantly in the areas of imaging -- heart blood flow and function as well as the cardiac autonomic nervous system.
He is well-regarded in the field of Nuclear Cardiology, being frequently invited to speak on various subjects in the field but especially SPECT imaging and quantification. Dr. Corbett is a regular reviewer for six medical publications, including Circulation, the Journal of American College of Cardiology, Journal of Nuclear Cardiology and the American Heart Journal. He has been a member of the Board of Directors of the Cardiovascular Council of the Society of Nuclear Medicine and Chairman of the Attenuation Correction Task Force and Chairman of the Equilibrium Radionuclide Ventriculography Imaging Guidelines Writing Group for the American Society of Nuclear Cardiology.
Dr. Corbett has a B.S. degree in Mechanical Engineering from the University of North Dakota, as well as an M.D. from the University of Minnesota.
Dr. Edward Ficaro
Dr. Ficaro is the President of INVIA, responsible for overall operations of the company, with a focus on the technical development of new imaging and software products.
He has 15 years of experience in nuclear cardiology, with a primary focus on algorithm development for modeling physiologic processes. That experience was gained through appointments at the Division of Nuclear Medicine at the University of Michigan Medical Center, initially as a Research Investigator, then and at present as Assistant Research Scientist.
He continues teaching a course in nuclear medicine, Biomedical Engineering, at the University of Michigan.
Dr. Ficaro has been extensively invited by global institutions and companies to speak on the topics of Nuclear Cardiology and Imaging Software. Over the past ten years, he has accepted more than 70 such speaking engagements around the world. Likewise, he has written and has been widely published in peer-review publications, non-peer review publication, book chapters and abstracts, with over 125 such writings to his credit.
Dr. Ficaro is a member of the Board of Directors of both the American Society of Nuclear Cardiology (ASNC), and he is the Chairman for the Quality Assurance Committee for ASNC. Dr. Ficaro also serves as a consultant physicist for Intersocietal Commission for the Accreditation of Nuclear Medicine Laboratories (ICANL).
Additionally, Dr. Ficaro is a reviewer for several nuclear medicine journals. His BS, MS degrees, and Ph.D., in Nuclear Engineering, are from the University of Michigan.
The User-Centered Experience
"The strengths of 4DM-SPECT are its ease of use, flexibility, and many user configurable options."
Dr. Corbett is the Chairman of the Board of INVIA. In that position he is responsible for the strategic direction of the Company, as well as directing clinical validation.
Dr. Ficaro is the President of INVIA, responsible for overall operations of the company, with a focus on the technical development of new imaging and software products.